Cargando…
Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
Recent studies have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors play a beneficial role for normoglycemic patients with heart failure (HF). However, the underlying mechanism remains largely unexplored. In the present study, we aimed to investigate the cardioprotective effect of SGLT2...
Autores principales: | Chen, Xuefeng, Yang, Qian, Bai, Wenlou, Yao, Wenjing, Liu, Litian, Xing, Yuanyuan, Meng, Cunliang, Qi, Peng, Dang, Yi, Qi, Xiaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136228/ https://www.ncbi.nlm.nih.gov/pubmed/35645838 http://dx.doi.org/10.3389/fphar.2022.873108 |
Ejemplares similares
-
Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice
por: Marcińczyk, Natalia, et al.
Publicado: (2023) -
Aspirin attenuates liver fibrosis by suppressing TGF-β1/Smad signaling
por: Sun, Yimin, et al.
Publicado: (2022) -
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021) -
Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report
por: Matli, Venkata Vinod Kumar, et al.
Publicado: (2021) -
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
por: Chen, Zhengjie, et al.
Publicado: (2022)